Skip to content

Impact of Hybrid-ESD+ and LiftUp® on the en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm

Impact of Using Hybrid-ESD+ and LiftUp® as Injectable on en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05517369
Acronym
HADRIAN
Enrollment
0
Registered
2022-08-26
Start date
2023-03-01
Completion date
2024-10-31
Last updated
2023-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Adenoma

Keywords

Hybrid-ESD+, Endoscopic Resection

Brief summary

This study examines whether the use of Hybrid-ESD+ with LiftUp (Injection solution) results in a higher en bloc and/or R0 rate for non pedunculated colorectal adenomas between 2 and 3 cm than described in the literature for conventional EMR.

Detailed description

There are several options for endoscopic polypectomy of polyps between 2-3 cm, all of which have their advantages and disadvantages and none of which has yet become the established standard procedure. Conventional EMR has the disadvantage of more frequent residuals and/or recurrences due to lack of en bloc resection, while ESD has the disadvantage of being more complex and complications more likely. A possible alternative is the use of hybrid ESD+ with LiftUp subcutaneous injection. The method with the LiftUp gel forming a stable gel cushion under the lesion, in combination with the circular circumcision of the mucosa at this site and the AWC for the current loop and the grasper, could achieve a better en bloc resection rate with a low complication rate than other procedures mentioned above. The higher effectiveness in terms of recurrences and complications could subsequently result in a reduction of endoscopic or surgical re-interventions. In this study, non-pedunculated colorectal polyps between 2 and 3cm in size are resected using ESD+ method and lift up as an injection solution. Methodological and clinical parameters are recorded. After 4 weeks, the patients are contacted by telephone to record possible late effects. If an endoscopic control is performed after 6 months (according to the guideline or according to the investigator), the findings are also recorded.

Interventions

PROCEDUREHybrid ESD+

Injection of the Lift Up solution, followed by circumcision of the lesion using a snare tip or ESD knife. Using an additional working channel (AWC), the lesion is resected using a grasper and snare.

Sponsors

Waid City Hospital, Zurich
CollaboratorOTHER
University Hospital Ulm
CollaboratorOTHER
Rems-Murr-Klinikum Winnenden
CollaboratorUNKNOWN
Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
Klinikum Ludwigsburg
CollaboratorOTHER
Mathilden Hospital Herford
CollaboratorUNKNOWN
St. Franziskus Hospital Münster
CollaboratorUNKNOWN
Agaplesion Kliniken Kassel
CollaboratorUNKNOWN
Ovesco Endoscopy AG
CollaboratorINDUSTRY
Wuerzburg University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Non-pedunculated lesion in the colorectum (epithelial lesion, 2-3 cm). * Ablation medically indicated and possible (coagulation, etc. - as determined by the center)

Exclusion criteria

* Age \< 18 years * Pedunculated lesion (Paris0-Ip) * Size of the lesion \<2cm or \>3cm * Pregnant and breastfeeding women * Patient not capable of informed consent / consent not possible * Bioptic evidence of a carcinoma / high probability of the presence of a carcinoma * Non-lifting sign / known recurrence after previous therapy * Impassable stenosis in the colon / rectum * Patients with compelling need for therapeutic anticoagulation or dual antiplatelet therapy that cannot be discontinued for resection * As per contraindications from the AWC & LiftUp Instructions for Use: * The AWC is not to be used if flexible-endoscopic procedures are contraindicated. * The LiftUp gel should not be used when flexible endoscopic procedures are contraindicated, especially in combination with submucosal endoscopic resection (EMR) or endoscopic submucosal dissection (ESD) injectables. * LiftUp gel should not be used in patients with known sensitivity to any of the ingredients.

Design outcomes

Primary

MeasureTime frameDescription
R0 resection rate of non pedunculated colorectal polyps between 2 and 3cm using hybrid ESD+after 14 daysIn how many cases a complete R0 resection (basal and lateral margin) is found on pathologic examination

Secondary

MeasureTime frameDescription
Recurrence rate6 monthsRate of adenoma residue and/or adenoma recurrence in percent after 6 months. This is determined by the colonoscopic and histologic findings from 2 biopsies from the scar or resection specimen.
Procedural parameters - Intervention duration1 dayIntervention duration (time range from injection to complete resection)
Procedural parameters - Cleanliness of the colon1 dayCleanliness of the colon (according to the Boston Bowel Preparation Scale (BBPS) 0-9)
Localization of polyp1 dayPosition of the polyp within the colon (Coecum, Ascendens, Transversum, Deschendens, Sigmoid, Rectum)
Complication rate (perforations, bleeding)up to 4 weeksPerforation: dehiscence of the muscularis propria diagnosed during or after resection. Hemorrhage: * Clinically significant post-endoscopic bleeding (CSPEB). Bleeding from the ablation site with hematochezia after completion of index colonoscopy * Intraprocedural bleeding (IPB). Percent, defined as bleeding lasting \> 60 seconds during intervention necessitating therapy
Polyp morphology1 dayaccording to paris classification
Polyp histology7 dayshistological examination (tubular, tubulovillous, villous)
Duration of hospital stayup to 4 weeksTime frame from first day to discharge
Polyp size1 dayPolyp diameter in mm

Countries

Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026